Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Leukemia, Myeloid, Acute 25Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Myelodysplastic Syndromes 16Hodgkin Disease 13Lymphoma, Non-Hodgkin 11Lymphoma, Large B-Cell, Diffuse 8Lymphoma 8Leukemia, Biphenotypic, Acute 8Leukemia 8Burkitt Lymphoma 7Breast Neoplasms 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Neuroblastoma 5Neoplasms 5Lymphoma, Mantle-Cell 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Hematologic Neoplasms 5Triple Negative Breast Neoplasms 4Sarcoma 4Rhabdomyosarcoma 4Multiple Myeloma 4Lymphoma, Follicular 4Anemia, Refractory, with Excess of Blasts 4Medulloblastoma 3Leukemia, Myelomonocytic, Chronic 3Carcinoma, Non-Small-Cell Lung 3Recurrence 2Myeloproliferative Disorders 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Anaplastic 2

Interventions

atezolizumab 3Specimen Handling 2spartalizumab 1selinexor 1sargramostim 1pembrolizumab 1pazopanib 1fludarabine 1cediranib 1cabozantinib 1atropine sulfate-diphenoxylate hydrochloride drug combination 1anlotinib 1Zoledronic Acid 1Warfarin 1Vitamin B 6 1Thyroxine 1Tablets 1Sunitinib 1Rosuvastatin Calcium 1Radiotherapy 1Radiation 1Pyridoxine 1Promethazine 1Prochlorperazine 1Petrolatum 1Midazolam 1Lorazepam 1Loperamide 1Immunoglobulin G 1Ifosfamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Alveolar Soft Part × Filgrastim × 1 year × Clear all
NCT01391962 2026-02-02

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
34 enrolled 22 charts
Sarcoma

Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon âš¡